Your browser doesn't support javascript.
loading
Risks associated with vaccinia virus in the laboratory.
MacNeil, Adam; Reynolds, Mary G; Damon, Inger K.
Affiliation
  • MacNeil A; National Center for Zoonotic, Vector-Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. aho3@cdc.gov
Virology ; 385(1): 1-4, 2009 Mar 01.
Article in En | MEDLINE | ID: mdl-19118854
Vaccinia virus (VACV) is used commonly in research laboratories. Non-highly attenuated strains of VACV are potentially pathogenic in humans, and VACV vaccination and biosafety level 2 facilities and protocols are currently recommended for vaccinated laboratory workers in the United States who handle non-highly attenuated strains of the virus. Despite this, laboratory-related VACV exposures continue to occur and a number of recent instances of VACV infection in non-vaccinated laboratory workers have been documented. We provide a discussion of the usage and risks associated with VACV in laboratory research.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccinia / Vaccinia virus / Laboratory Infection Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Virology Year: 2009 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccinia / Vaccinia virus / Laboratory Infection Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Virology Year: 2009 Document type: Article Affiliation country: Country of publication: